Skip to main content

Advertisement

Log in

Retrocrural Lymph Node Metastasis Disclosed by 18F-FDG PET/CT: A Predictor of Supra-diaphragmatic Spread in Ovarian Cancer

  • Original Article
  • Published:
Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

Retrocrural lymph nodes (RCLNs) communicate with retroperitoneal and posterior mediastinal LNs. It is possible that, when RCLNs are involved, supra-diaphragmatic extension will occur in abdomino-pelvic cancers. The authors investigated performance of 18F-FDG PET/CT to diagnose RCLN metastasis and whether RCLN metastases were associated with supra-diaphragmatic lymphatic metastases of ovarian cancer.

Materials and methods

Sixty-seven patients with stage IV ovarian cancer who had undergone 18F-FDG PET/CT were included in this retrospective study. Diagnostic performance of 18F-FDG PET/CT for RCLN metastasis was evaluated. Patients were divided into two groups by presence or absence of supra-diaphragmatic LN metastasis. The prevalences of RCLN metastasis between the two groups were compared and the odds ratio was calculated.

Results

Sensitivity and specificity of 18F-FDG PET/CT for RCLN metastasis were 96.3 and 100%, respectively. Of the 67 study subjects, 27 patients had RCLN metastases (40.3%). Fifty patients had supra-diaphragmatic LN metastases. 18F-FDG PET/CT showed 26 RCLN metastases in patients with supra-diaphragmatic LN metastases (54.5%), and only 1 in patients without supra-diaphragmatic LN metastasis (5.9%), and the difference between two groups was statistically significant (P < 0.05). The odds ratio that patients with RCLN metastasis would have supra-diaphragmatic LN metastasis was 17.3 (95% confidence interval = 2.1 to 140.9, P = 0.008).

Conclusion

Performance of 18F-FDG PET/CT to diagnose RCLN metastasis was excellent. RCLN metastasis revealed by 18F-FDG PET/CT was strongly associated with supra-diaphragmatic LN spread of ovarian cancer. Thus, RCLN metastasis could be used as a predictor of supra-diaphragmatic lymphatic metastasis of ovarian cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

    Article  PubMed  Google Scholar 

  2. Jung KW, Park SH, Kong HJ, Won YJ, Boo YK, Shin HR et al. Cancer statistics in Korea: incidence, mortality and survival in 2006–2007. J Korean Med Sci. 2010;25:1113–21.

    Article  PubMed  Google Scholar 

  3. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W et al. SEER cancer statistics review, 1975–2007. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.

  4. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual, 7th ed. Chicago: American Joint Committee on Cancer; 2009.

    Google Scholar 

  5. Restrepo CS, Eraso A, Ocazionez D, Lemos J, Martinez S, Lemos DF. The diaphragmatic crura and retrocrural space: normal imaging appearance, variants, and pathologic conditions. Radiographics. 2008;28:1289–305.

    Article  PubMed  Google Scholar 

  6. Suwatanapongched T, Gierada DS. CT of thoracic lymph nodes. Part I: anatomy and drainage. Br J Radiol. 2006;79:922–8.

    Article  PubMed  CAS  Google Scholar 

  7. Shin MS, Berland LL. Computed tomography of retrocrural spaces: normal, anatomic variants, and pathologic conditions. AJR Am J Roentgenol. 1985;145:81–6.

    Google Scholar 

  8. Kawamura J, Hida S, Higashi Y, Yamauchi T, Yoshida O. Diagnosis of retroperitoneal lymph node swelling by computed tomography in advanced testicular cancer patients, with special reference to retrocrural lymph node swelling. Hinyokika Kiyo. 1985;31:1105–16.

    PubMed  CAS  Google Scholar 

  9. Beggs AD, Hain SF, Curran KM, O'Doherty MJ. FDG-PET as a "metabolic biopsy" tool in non-lung lesions with indeterminate biopsy. Eur J Nucl Med Mol Imaging. 2002;29:542–6.

    Article  PubMed  CAS  Google Scholar 

  10. Patz Jr EF, Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology. 1993;188:487–90.

    PubMed  Google Scholar 

  11. Dauplat J, Hacker NF, Nieberg RK, Berek JS, Rose TP, Sagae S. Distant metastases in epithelial ovarian carcinoma. Cancer. 1987;60:1561–6.

    Article  PubMed  CAS  Google Scholar 

  12. Klein KA, Stephens DH, Welch TJ. CT characteristics of metastatic disease of the pancreas. Radiographics. 1998;18:369–78.

    PubMed  CAS  Google Scholar 

  13. Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR et al. Radiology. 1991;178:705–13.

    PubMed  CAS  Google Scholar 

  14. van den Brekel MW, Stel HV, Castelijns JA, Nauta JJ, van der Waal I, Valk J et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology. 1990;177:379–84.

    PubMed  Google Scholar 

  15. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.

    Article  PubMed  CAS  Google Scholar 

  16. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50:122S–50S.

    Article  PubMed  CAS  Google Scholar 

  17. Liu FY, Lin CY, Chang JT, Ng SH, Chin SC, Wang HM et al. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma. J Nucl Med. 2007;48:1614–9.

    Article  PubMed  Google Scholar 

  18. Hubner KF, McDonald TW, Niethammer JG, Smith GT, Gould HR, Buonocore E. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). Gynecol Oncol. 1993;51:197–204.

    Article  PubMed  CAS  Google Scholar 

  19. Tran BN, Grigsby PW, Dehdashti F, Herzog TJ, Siegel BA. Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix. Gynecol Oncol. 2003;90:572–6.

    Article  PubMed  Google Scholar 

  20. Gontier E, Wartski M, Guinebretiere JM, Alberini JL. 18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma. AJR Am J Roentgenol. 2006;187:W285–9.

    Article  PubMed  Google Scholar 

  21. Burns N, Barksdale J, Ho L, Colletti PM. Imaging of the cisterna chyli on PET-CT in patients with known malignancy: Report of two cases. Radiol Case Rep. 2009;4:269.

    Article  Google Scholar 

  22. Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol. 2008;38:347–53.

    Article  PubMed  Google Scholar 

  23. Kobayashi S, Nagano H, Hoshino H, Wada H, Marubashi S, Eguchi H et al. Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer. J Surg Oncol. 2011;103(3):223–9. doi:10.1002/jso.21811

    Google Scholar 

  24. Callen PW, Korobkin M, Isherwood I. Computed tomographic evaluation of the retrocrural prevertebral space. AJR Am J Roentgenol. 1977;129:907–10.

    PubMed  CAS  Google Scholar 

  25. Mahon TG, Libshitz HI. Mediastinal metastases of infradiaphragmatic malignancies. Eur J Radiol. 1992;15:130–4.

    Article  PubMed  CAS  Google Scholar 

  26. Kitajima K, Murakami K, Yamasaki E, Fukasawa I, Inaba N, Kaji Y et al. Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. AJR AM J Roentgenol. 2008;190:1652–8.

    Article  PubMed  Google Scholar 

  27. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25:1255–60.

    Article  PubMed  CAS  Google Scholar 

  28. Dvoretsky PM, Richards KA, Angel C, Rabinowitz L, Stoler MH, Beecham JB et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol. 1988;19:57–63.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by grant no. R31-2008-000-10103-0 from the WCU project of the Korean Ministry of Education, Science and Technology (MEST) and the National Research Foundation of Korea (NRF). Figure 1 was illustrated and kindly provided by Doctor Yongwonn Kwon.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to June-Key Chung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Im, HJ., Kim, Yi., Paeng, J.C. et al. Retrocrural Lymph Node Metastasis Disclosed by 18F-FDG PET/CT: A Predictor of Supra-diaphragmatic Spread in Ovarian Cancer. Nucl Med Mol Imaging 46, 41–47 (2012). https://doi.org/10.1007/s13139-011-0115-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13139-011-0115-7

Keywords

Navigation